Compare IMO & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMO | ELV |
|---|---|---|
| Founded | 1880 | 1944 |
| Country | Canada | United States |
| Employees | N/A | 97100 |
| Industry | Integrated oil Companies | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7B | 86.6B |
| IPO Year | 2002 | 2001 |
| Metric | IMO | ELV |
|---|---|---|
| Price | $133.62 | $401.80 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 19 |
| Target Price | $116.00 | ★ $383.56 |
| AVG Volume (30 Days) | 430.4K | ★ 1.2M |
| Earning Date | 05-01-2026 | 04-22-2026 |
| Dividend Yield | 1.68% | ★ 1.83% |
| EPS Growth | N/A | ★ N/A |
| EPS | 6.46 | ★ 14.73 |
| Revenue | $47,078,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $15.67 | N/A |
| Revenue Next Year | N/A | $3.07 |
| P/E Ratio | ★ $20.53 | $27.03 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $82.45 | $274.89 |
| 52 Week High | $139.44 | $436.24 |
| Indicator | IMO | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 67.41 | 56.65 |
| Support Level | $119.62 | $382.77 |
| Resistance Level | $139.44 | $408.00 |
| Average True Range (ATR) | 3.12 | 10.87 |
| MACD | 0.45 | 2.52 |
| Stochastic Oscillator | 89.89 | 92.88 |
Imperial Oil Ltd is an integrated oil company active in all phases of the petroleum industry in Canada, including the exploration for, and production and sale of, crude oil, natural gas, petroleum products, and petrochemicals. It also pursues lower-emission business opportunities, including carbon capture and storage, hydrogen, lower-emission fuels, and lithium. The company's reportable segments are Upstream, Downstream, and Chemical. Maximum revenue for the company is generated from its Downstream segment, which refines crude oil into petroleum products and distributes and market these products. The Upstream segment explores and produces crude oil, its equivalents, and natural gas, and the Chemical segment manufactures and markets hydrocarbon-based chemicals and chemical products.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.